{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:55:37Z","timestamp":1793372137004,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Light Sci Appl"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cup-like nuclear morphological alterations in acute myeloid leukemia (AML) blasts have been widely correlated with Nucleophosmin 1 (NPM1) mutations. NPM1-mutated AML has earned recognition as a distinct entity among myeloid tumors, but the absence of a thoroughly established tool for its morphological analysis remains a notable gap. Holographic tomography (HT) can offer a label-free solution for quantitatively assessing the 3D shape of the nucleus based on the volumetric variations of its refractive indices (RIs). However, traditional HT methods analyze adherent cells in a 2D layer, leading to non-isotropic reconstructions due to missing cone artifacts. Here we show for the first time that holo-tomographic flow cytometry (HTFC) achieves quantitative specificity and precise capture of the nucleus volumetric shape in AML cells in suspension. To retrieve nucleus specificity in label-free RI tomograms of flowing AML cells, we conceive and demonstrate in a real-world clinical case a novel strategy for segmenting 3D concave nuclei. This method implies that the correlation between the \u201cphenotype\u201d and \u201cgenotype\u201d of nuclei is demonstrated through HTFC by creating a challenging link not yet explored between the aberrant morphological features of AML nuclei and NPM1 mutations. We conduct an ensemble-level statistical characterization of NPM1-wild type and NPM1-mutated blasts to discern their complex morphological and biophysical variances. Our findings suggest that characterizing cup-like nuclei in NPM1-related AML cells by HTFC may enhance the diagnostic approach for these tumors. Furthermore, we integrate virtual reality to provide an immersive fruition of morphological changes in AML cells within a true 3D environment.<\/jats:p>","DOI":"10.1038\/s41377-025-01913-y","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T07:05:50Z","timestamp":1751439950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["From genotype to phenotype: decoding mutations in blasts by holo-tomographic flow cytometry"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1317-7545","authenticated-orcid":false,"given":"Daniele","family":"Pirone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Di Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Di Summa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Schiavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Florio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Marasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luca","family":"Maffettone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Miccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9607-7728","authenticated-orcid":false,"given":"Pasquale","family":"Memmolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"1913_CR1","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1182\/blood.2019004226","volume":"136","author":"B Falini","year":"2020","unstructured":"Falini, B. et al. NPM1-mutated acute myeloid leukemia: from bench to bedside. Blood 136, 1707\u20131721 (2020).","journal-title":"Blood"},{"key":"1913_CR2","doi-asserted-by":"crossref","unstructured":"Falini, B. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features. In Acute Myelogenous Leukemia: Genetics, Biology and Therapy (ed Nagarajan, L.) 149\u2013168 (Springer, New York, 2009).","DOI":"10.1007\/978-0-387-69259-3_9"},{"key":"1913_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/pro.2240","volume":"22","author":"L Federici","year":"2013","unstructured":"Federici, L. & Falini, B. Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization. Protein Sci. 22, 545\u2013556 (2013).","journal-title":"Protein Sci."},{"key":"1913_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/bies.20512","volume":"29","author":"LJ Frehlick","year":"2007","unstructured":"Frehlick, L. J., Eir\u00edn-L\u00f3pez, J. M. & Ausi\u00f3, J. New insights into the nucleophosmin\/nucleoplasmin family of nuclear chaperones. Bioessays 29, 49\u201359 (2007).","journal-title":"Bioessays"},{"key":"1913_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0014-5793(01)02939-8","volume":"506","author":"M Okuwaki","year":"2001","unstructured":"Okuwaki, M. et al. Function of nucleophosmin\/B23, a nucleolar acidic protein, as a histone chaperone. FEBS Lett. 506, 272\u2013276 (2001).","journal-title":"FEBS Lett."},{"key":"1913_CR6","doi-asserted-by":"publisher","first-page":"6230","DOI":"10.1158\/0008-5472.CAN-07-0273","volume":"67","author":"N Bolli","year":"2007","unstructured":"Bolli, N. et al. Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants. Cancer Res. 67, 6230\u20136237 (2007).","journal-title":"Cancer Res."},{"key":"1913_CR7","doi-asserted-by":"publisher","first-page":"59129","DOI":"10.18632\/oncotarget.10991","volume":"7","author":"PL Scognamiglio","year":"2016","unstructured":"Scognamiglio, P. L. et al. Destabilisation, aggregation, toxicity and cytosolic mislocalisation of nucleophosmin regions associated with acute myeloid leukemia. Oncotarget 7, 59129\u201359143 (2016).","journal-title":"Oncotarget"},{"key":"1913_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bbapap.2019.01.010","volume":"1867","author":"C Di Natale","year":"2019","unstructured":"Di Natale, C. et al. Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in type A mutation of acute myeloid leukemia. Biochim. Biophys. Acta Proteins Proteom. 1867, 637\u2013644 (2019).","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"1913_CR9","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1096\/fj.14-269522","volume":"29","author":"C Di Natale","year":"2015","unstructured":"Di Natale, C. et al. Nucleophosmin contains amyloidogenic regions that are able to form toxic aggregates under physiological conditions. FASEB J. 29, 3689\u20133701 (2015).","journal-title":"FASEB J."},{"key":"1913_CR10","doi-asserted-by":"publisher","first-page":"23326","DOI":"10.1074\/jbc.M801706200","volume":"283","author":"CG Grummitt","year":"2008","unstructured":"Grummitt, C. G. et al. Structural consequences of nucleophosmin mutations in acute myeloid leukemia. J. Biol. Chem. 283, 23326\u201323332 (2008).","journal-title":"J. Biol. Chem."},{"key":"1913_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1158\/2643-3230.BCD-23-0144","volume":"5","author":"B Falini","year":"2024","unstructured":"Falini, B. & Dillon, R. Criteria for diagnosis and molecular monitoring of NPM1-mutated AML. Blood Cancer Discov. 5, 8\u201320 (2024).","journal-title":"Blood Cancer Discov."},{"key":"1913_CR12","doi-asserted-by":"crossref","unstructured":"Behdad, A. & Betz, B. L. Molecular testing in acute myeloid leukemia. In Diagnostic Molecular Pathology: A Guide to Applied Molecular Testing 2nd edn (eds Coleman, W. B. & Tsongalis, G. J.) 597\u2013615 (Academic Press, London, 2024).","DOI":"10.1016\/B978-0-12-822824-1.00019-5"},{"key":"1913_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.blre.2017.11.001","volume":"32","author":"P Kunchala","year":"2018","unstructured":"Kunchala, P. et al. When the good go bad: mutant NPM1 in acute myeloid leukemia. Blood Rev. 32, 167\u2013183 (2018).","journal-title":"Blood Rev."},{"key":"1913_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1182\/blood.2020008211","volume":"137","author":"B Falini","year":"2021","unstructured":"Falini, B., Brunetti, L. & Martelli, M. P. How I diagnose and treat NPM1-mutated AML. Blood 137, 589\u2013599 (2021).","journal-title":"Blood"},{"key":"1913_CR15","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1038\/s41375-021-01222-4","volume":"35","author":"B Falini","year":"2021","unstructured":"Falini, B. et al. Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field. Leukemia 35, 3113\u20133126 (2021).","journal-title":"Leukemia"},{"key":"1913_CR16","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/s41375-022-01666-2","volume":"36","author":"R Ranieri","year":"2022","unstructured":"Ranieri, R. et al. Current status and future perspectives in targeted therapy of NPM1-mutated AML. Leukemia 36, 2351\u20132367 (2022).","journal-title":"Leukemia"},{"key":"1913_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/ijlh.13317","volume":"43","author":"RAER El-Gamal","year":"2021","unstructured":"El-Gamal, R. A. E. R. et al. Flow cytometry in detection of Nucleophosmin 1 mutation in acute myeloid leukemia patients: a reproducible tertiary hospital experience. Int. J. Lab. Hematol. 43, 68\u201375 (2021).","journal-title":"Int. J. Lab. Hematol."},{"key":"1913_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/jha2.866","volume":"5","author":"Q Wei","year":"2024","unstructured":"Wei, Q. et al. Diagnostic utility of immunohistochemistry in detection of NPM1 mutations in acute myeloid leukemia with a patchy distribution. eJHaem 5, 379\u2013382 (2024).","journal-title":"eJHaem"},{"key":"1913_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.701318","volume":"11","author":"A Lopez","year":"2021","unstructured":"Lopez, A. et al. Comparison of multiple clinical testing modalities for assessment of NPM1-mutant AML. Front. Oncol. 11, 701318 (2021).","journal-title":"Front. Oncol."},{"key":"1913_CR20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.5858\/arpa.2021-0601-OA","volume":"147","author":"PR Menegotto","year":"2023","unstructured":"Menegotto, P. R. et al. Comparison of nonsequencing techniques for identification of NPM1 mutations and associated blast morphology in patients with acute myeloid leukemia. Arch. Pathol. Lab. Med. 147, 701\u2013709 (2023).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"1913_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41566-018-0253-x","volume":"12","author":"Y Park","year":"2018","unstructured":"Park, Y., Depeursinge, C. & Popescu, G. Quantitative phase imaging in biomedicine. Nat. Photonics 12, 578\u2013589 (2018).","journal-title":"Nat. Photonics"},{"key":"1913_CR22","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1039\/C5LC01445J","volume":"16","author":"PY Liu","year":"2016","unstructured":"Liu, P. Y. et al. Cell refractive index for cell biology and disease diagnosis: past, present and future. Lab Chip 16, 634\u2013644 (2016).","journal-title":"Lab Chip"},{"key":"1913_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s43586-024-00327-1","volume":"4","author":"G Kim","year":"2024","unstructured":"Kim, G. et al. Holotomography. Nat. Rev. Methods Prim. 4, 51 (2024).","journal-title":"Nat. Rev. Methods Prim."},{"key":"1913_CR24","doi-asserted-by":"publisher","first-page":"B65","DOI":"10.1364\/AO.416902","volume":"60","author":"V Balasubramani","year":"2021","unstructured":"Balasubramani, V. et al. Holographic tomography: techniques and biomedical applications [Invited]. Appl. Opt. 60, B65\u2013B80 (2021).","journal-title":"Appl. Opt."},{"key":"1913_CR25","doi-asserted-by":"crossref","unstructured":"Kim, D. et al. Holotomography: refractive index as an intrinsic imaging contrast for 3-D label-free live cell imaging. In Advanced Imaging and Bio Techniques for Convergence Science (eds Kim, J. K., Kim, J. K. & Pack, C. G.) 211\u2013238 (Springer, Singapore, 2021).","DOI":"10.1007\/978-981-33-6064-8_10"},{"key":"1913_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201800761","volume":"5","author":"M Ugele","year":"2018","unstructured":"Ugele, M. et al. Label\u2010free high\u2010throughput leukemia detection by holographic microscopy. Adv. Sci. 5, 1800761 (2018).","journal-title":"Adv. Sci."},{"key":"1913_CR27","volume-title":"Proceedings of SPIE PC12852, Quantitative Phase Imaging X.","author":"H Kim","year":"2024","unstructured":"Kim, H. et al. Label-free cytological characterization of blasts with NPM1 mutation using holotomography and machine learning. Proceedings of SPIE PC12852, Quantitative Phase Imaging X. (SPIE, San Francisco, CA, 2024)."},{"key":"1913_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75168-9","volume":"14","author":"H Kim","year":"2024","unstructured":"Kim, H. et al. Integrating holotomography and deep learning for rapid detection of NPM1 mutations in AML. Sci. Rep. 14, 23780 (2024).","journal-title":"Sci. Rep."},{"key":"1913_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41375-021-01408-w","volume":"36","author":"JN Eckardt","year":"2022","unstructured":"Eckardt, J. N. et al. Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears. Leukemia 36, 111\u2013118 (2022).","journal-title":"Leukemia"},{"key":"1913_CR30","doi-asserted-by":"publisher","first-page":"23920","DOI":"10.1364\/OE.25.023920","volume":"25","author":"J Kostencka","year":"2017","unstructured":"Kostencka, J., Kozacki, T. & J\u00f3zwik, M. Holographic tomography with object rotation and two-directional off-axis illumination. Opt. Express 25, 23920\u201323934 (2017).","journal-title":"Opt. Express"},{"key":"1913_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/lsa.2016.241","volume":"6","author":"F Merola","year":"2017","unstructured":"Merola, F. et al. Tomographic flow cytometry by digital holography. Light Sci. Appl. 6, e16241 (2017).","journal-title":"Light Sci. Appl."},{"key":"1913_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32110-9","volume":"13","author":"D Pirone","year":"2023","unstructured":"Pirone, D. et al. Label-free liquid biopsy through the identification of tumor cells by machine learning-powered tomographic phase imaging flow cytometry. Sci. Rep. 13, 6042 (2023).","journal-title":"Sci. Rep."},{"key":"1913_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/adom.202400164","volume":"12","author":"D Pirone","year":"2024","unstructured":"Pirone, D. et al. Bio\u2010engineering yeast cells biolenses by reshaping intracellular vacuoles. Adv. Optical Mater. 12, 2400164 (2024).","journal-title":"Adv. Optical Mater."},{"key":"1913_CR34","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41566-022-01096-7","volume":"16","author":"D Pirone","year":"2022","unstructured":"Pirone, D. et al. Stain-free identification of cell nuclei using tomographic phase microscopy in flow cytometry. Nat. Photonics 16, 851\u2013859 (2022).","journal-title":"Nat. Photonics"},{"key":"1913_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202300447","volume":"7","author":"V Bianco","year":"2023","unstructured":"Bianco, V. et al. Label\u2010free intracellular multi\u2010specificity in yeast cells by phase\u2010contrast tomographic flow cytometry. Small Methods 7, 2300447 (2023).","journal-title":"Small Methods"},{"key":"1913_CR36","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.3390\/ijms24065377","volume":"24","author":"R Skopek","year":"2023","unstructured":"Skopek, R. et al. Choosing the right cell line for acute myeloid leukemia (AML) research. Int. J. Mol. Sci. 24, 5377 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1913_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2022.130173","volume":"1866","author":"S La Manna","year":"2022","unstructured":"La Manna, S. et al. Type C mutation of nucleophosmin 1 acute myeloid leukemia: Consequences of intrinsic disorder. Biochim. Biophys. Acta Gen. Subj. 1866, 130173 (2022).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"1913_CR38","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1182\/blood-2006-03-014340","volume":"108","author":"WN Chen","year":"2006","unstructured":"Chen, W. N. et al. High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations (\u201ccuplike\u201d nuclei). Blood 108, 1783\u20131784 (2006).","journal-title":"Blood"},{"key":"1913_CR39","doi-asserted-by":"publisher","first-page":"e28365e6","DOI":"10.1097\/01.HS9.0000974440.28365.e6","volume":"7","author":"L Jakovic","year":"2023","unstructured":"Jakovic, L. et al. PB1904: Can \u201ecup like\u201c nuclear cytomorphology predict nucleophosmin mutated status in patients with acute myeloid leukemia? HemaSphere 7, e28365e6 (2023).","journal-title":"HemaSphere"},{"key":"1913_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/hon.1011","volume":"30","author":"A Ferrari","year":"2012","unstructured":"Ferrari, A. et al. Immunophenotype distinction between acute promyelocytic leukaemia and CD15\u2212 CD34\u2212 HLA\u2010DR\u2212 acute myeloid leukaemia with nucleophosmin mutations. Hematol. Oncol. 30, 109\u2013114 (2012).","journal-title":"Hematol. Oncol."},{"key":"1913_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3324\/haematol.11669","volume":"93","author":"FP Kroschinsky","year":"2008","unstructured":"Kroschinsky, F. P. et al. Cup-like acute myeloid leukemia: New disease or artificial phenomenon? Haematologica 93, 283\u2013286 (2008).","journal-title":"Haematologica"},{"key":"1913_CR42","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1242\/jcs.037333","volume":"122","author":"M Webster","year":"2009","unstructured":"Webster, M., Witkin, K. L. & Cohen-Fix, O. Sizing up the nucleus: nuclear shape, size and nuclear-envelope assembly. J. Cell Sci. 122, 1477\u20131486 (2009).","journal-title":"J. Cell Sci."},{"key":"1913_CR43","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.jmb.2019.01.033","volume":"431","author":"M El Beheiry","year":"2019","unstructured":"El Beheiry, M. et al. Virtual reality: beyond visualization. J. Mol. Biol. 431, 1315\u20131321 (2019).","journal-title":"J. Mol. Biol."},{"key":"1913_CR44","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1016\/j.jmb.2018.06.035","volume":"430","author":"C Stefani","year":"2018","unstructured":"Stefani, C., Lacy-Hulbert, A. & Skillman, T. ConfocalVR: immersive visualization for confocal microscopy. J. Mol. Biol. 430, 4028\u20134035 (2018).","journal-title":"J. Mol. Biol."},{"key":"1913_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/tra.12538","volume":"19","author":"APR Johnston","year":"2018","unstructured":"Johnston, A. P. R. et al. Journey to the centre of the cell: virtual reality immersion into scientific data. Traffic 19, 105\u2013110 (2018).","journal-title":"Traffic"},{"key":"1913_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2023.103054","volume":"85","author":"D Pirone","year":"2024","unstructured":"Pirone, D. et al. Beyond fluorescence: advances in computational label-free full specificity in 3D quantitative phase microscopy. Curr. Opin. Biotechnol. 85, 103054 (2024).","journal-title":"Curr. Opin. Biotechnol."},{"key":"1913_CR47","doi-asserted-by":"publisher","first-page":"9223","DOI":"10.1073\/pnas.1919569117","volume":"117","author":"YN Nygate","year":"2020","unstructured":"Nygate, Y. N. et al. Holographic virtual staining of individual biological cells. Proc. Natl. Acad. Sci. USA 117, 9223\u20139231 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1913_CR48","doi-asserted-by":"publisher","first-page":"18302","DOI":"10.1073\/pnas.2001754117","volume":"117","author":"ME Kandel","year":"2020","unstructured":"Kandel, M. E. et al. Reproductive outcomes predicted by phase imaging with computational specificity of spermatozoon ultrastructure. Proc. Natl. Acad. Sci. USA 117, 18302\u201318309 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1913_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41377-023-01104-7","volume":"12","author":"BJ Bai","year":"2023","unstructured":"Bai, B. J. et al. Deep learning-enabled virtual histological staining of biological samples. Light Sci. Appl. 12, 57 (2023).","journal-title":"Light Sci. Appl."},{"key":"1913_CR50","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/s41556-021-00802-x","volume":"23","author":"Y Jo","year":"2021","unstructured":"Jo, Y. et al. Label-free multiplexed microtomography of endogenous subcellular dynamics using generalizable deep learning. Nat. Cell Biol. 23, 1329\u20131337 (2021).","journal-title":"Nat. Cell Biol."},{"key":"1913_CR51","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00277-012-1645-5","volume":"92","author":"BG Park","year":"2013","unstructured":"Park, B. G. et al. Association of cup-like nuclei in blasts with FLT3 and NPM1 mutations in acute myeloid leukemia. Ann. Hematol. 92, 451\u2013457 (2013).","journal-title":"Ann. Hematol."},{"key":"1913_CR52","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.aci.2018.08.003","volume":"17","author":"A Tharwat","year":"2021","unstructured":"Tharwat, A. Classification assessment methods. Appl. Comput. Inform. 17, 168\u2013192 (2021).","journal-title":"Appl. Comput. Inform."},{"key":"1913_CR53","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer, C. et al. Cellpose: a generalist algorithm for cellular segmentation. Nat. Methods 18, 100\u2013106 (2021).","journal-title":"Nat. Methods"},{"key":"1913_CR54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.14445\/22312803\/IJCTT-V34P108","volume":"34","author":"A Chaturvedi","year":"2016","unstructured":"Chaturvedi, A., Khanna, R. & Kumar, V. An analysis of region growing image segmentation schemes. Int. J. Emerging Trends Technol. Comput. Sci. 34, 46\u201351 (2016).","journal-title":"Int. J. Emerging Trends Technol. Comput. Sci."},{"key":"1913_CR55","doi-asserted-by":"crossref","unstructured":"Nguyen, A. & Le, B. 3D point cloud segmentation: a survey. In Proc. 2013 6th IEEE Conference on Robotics, Automation and Mechatronics (RAM) 225\u2013230 (IEEE, Manila, 2016).","DOI":"10.1109\/RAM.2013.6758588"},{"key":"1913_CR56","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/sj.leu.2403458","volume":"18","author":"SJ Kussick","year":"2004","unstructured":"Kussick, S. J. et al. A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication. Leukemia 18, 1591\u20131598 (2004).","journal-title":"Leukemia"},{"key":"1913_CR57","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1002\/cncr.24610","volume":"115","author":"WN Chen","year":"2009","unstructured":"Chen, W. N. et al. Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation. Cancer 115, 5481\u20135489 (2009).","journal-title":"Cancer"},{"key":"1913_CR58","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1309\/AJCPULO8SLW0RKJL","volume":"134","author":"JM Bennett","year":"2010","unstructured":"Bennett, J. M. et al. Is the association of \u201ccup-like\u201d nuclei with mutation of the NPM1 gene in acute myeloid leukemia clinically useful? Am. J. Clin. Pathol. 134, 648\u2013652 (2010).","journal-title":"Am. J. Clin. Pathol."},{"key":"1913_CR59","doi-asserted-by":"crossref","unstructured":"Theodoridis, S. Classification: a tour of the classics. In Machine Learning: A Bayesian and Optimization Perspective (ed Theodoridis, S.) 275\u2013325 (Academic Press, London, 2015).","DOI":"10.1016\/B978-0-12-801522-3.00007-0"},{"key":"1913_CR60","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4103\/aca.ACA_94_19","volume":"22","author":"P Mishra","year":"2019","unstructured":"Mishra, P. et al. Application of student\u2019s t-test, analysis of variance, and covariance. Ann. Card. Anaesth. 22, 407\u2013411 (2019).","journal-title":"Ann. Card. Anaesth."},{"key":"1913_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10924","volume":"7","author":"J Koya","year":"2016","unstructured":"Koya, J. et al. DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation. Nat. Commun. 7, 10924 (2016).","journal-title":"Nat. Commun."},{"key":"1913_CR62","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1039\/D1LC01087E","volume":"22","author":"D Pirone","year":"2022","unstructured":"Pirone, D. et al. Speeding up reconstruction of 3D tomograms in holographic flow cytometry via deep learning. Lab Chip 22, 793\u2013804 (2022).","journal-title":"Lab Chip"}],"container-title":["Light: Science &amp; Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41377-025-01913-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41377-025-01913-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41377-025-01913-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T08:03:12Z","timestamp":1751443392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41377-025-01913-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1913"],"URL":"https:\/\/doi.org\/10.1038\/s41377-025-01913-y","relation":{},"ISSN":["2047-7538"],"issn-type":[{"value":"2047-7538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Pietro Ferraro serves as an Editor for the Journal. No other author has reported any conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"233"}}